KalGen Laboratory

We are molecular pathology laboratory specializing in genetic testing to deliver personalized medicine in timely and accurate manner. Operating in Jakarta, KalGen Laboratory is ISO15189 accredited for both KRAS and EGFR mutation genetic testing. Currently KRAS and EGFR tests are required to match colorectal and lung cancer patients to cetuximab and tyrosine kinase inhibitors (gefitinib and erlotinib), respectively. Since 2009, KalGen has performed more than 1,000 genetic testing from various clinical samples such as formalin fixed paraffin embedded tissues and cytological samples. We have partnered with major pharmaceutical companies such as Merck Serono, Astra Zeneca, Roche, and Innogene Kalbiotech. Because...

Genetic mutation testing and screening,gene expression using immunohistochemistry method,personalized medicine,and quantitative gene expression using real time pcr platform

Kalgen laboratory operates in the Biotechnology industry.

Kalgen laboratory's revenue is 11m - 100m

Kalgen laboratory has 11 - 50 employees.